163 related articles for article (PubMed ID: 12534407)
1. Cost-effectiveness in Canada of intravenous proton pump inhibitors for all patients presenting with acute upper gastrointestinal bleeding.
Enns RA; Gagnon YM; Rioux KP; Levy AR
Aliment Pharmacol Ther; 2003 Jan; 17(2):225-33. PubMed ID: 12534407
[TBL] [Abstract][Full Text] [Related]
2. High-dose intravenous proton pump inhibition following endoscopic therapy in the acute management of patients with bleeding peptic ulcers in the USA and Canada: a cost-effectiveness analysis.
Barkun AN; Herba K; Adam V; Kennedy W; Fallone CA; Bardou M
Aliment Pharmacol Ther; 2004 Mar; 19(5):591-600. PubMed ID: 14987328
[TBL] [Abstract][Full Text] [Related]
3. Cost implications of administering intravenous proton pump inhibitors to all patients presenting to the emergency department with peptic ulcer bleeding.
Gagnon YM; Levy AR; Eloubeidi MA; Arguedas MR; Rioux KP; Enns RA
Value Health; 2003; 6(4):457-65. PubMed ID: 12859587
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of high-dose omeprazole infusion before endoscopy for patients with upper-GI bleeding.
Tsoi KK; Lau JY; Sung JJ
Gastrointest Endosc; 2008 Jun; 67(7):1056-63. PubMed ID: 18407271
[TBL] [Abstract][Full Text] [Related]
5. Timing or Dosing of Intravenous Proton Pump Inhibitors in Acute Upper Gastrointestinal Bleeding Has Low Impact on Costs.
Lu Y; Adam V; Teich V; Barkun A
Am J Gastroenterol; 2016 Oct; 111(10):1389-1398. PubMed ID: 27140030
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of proton-pump inhibition before endoscopy in upper gastrointestinal bleeding.
Al-Sabah S; Barkun AN; Herba K; Adam V; Fallone C; Mayrand S; Pomier-Layrargues G; Kennedy W; Bardou M
Clin Gastroenterol Hepatol; 2008 Apr; 6(4):418-25. PubMed ID: 18304891
[TBL] [Abstract][Full Text] [Related]
7. Pre-endoscopic proton pump inhibitor therapy reduces recurrent adverse gastrointestinal outcomes in patients with acute non-variceal upper gastrointestinal bleeding.
Keyvani L; Murthy S; Leeson S; Targownik LE
Aliment Pharmacol Ther; 2006 Oct; 24(8):1247-55. PubMed ID: 17014584
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of proton pump inhibitor therapy for acute peptic ulcer-related bleeding.
Erstad BL
Crit Care Med; 2004 Jun; 32(6):1277-83. PubMed ID: 15187506
[TBL] [Abstract][Full Text] [Related]
9. The cost-effectiveness of high-dose oral proton pump inhibition after endoscopy in the acute treatment of peptic ulcer bleeding.
Barkun AN; Herba K; Adam V; Kennedy W; Fallone CA; Bardou M
Aliment Pharmacol Ther; 2004 Jul; 20(2):195-202. PubMed ID: 15233700
[TBL] [Abstract][Full Text] [Related]
10. Editorial: Intravenous Proton Pump Inhibitors for Bleeding Peptic Ulcer: What is the Most Cost-Effective Approach?
Peterson K; Bjorkman DJ
Am J Gastroenterol; 2016 Oct; 111(10):1399-1401. PubMed ID: 27694876
[TBL] [Abstract][Full Text] [Related]
11. The role of intravenous proton pump inhibitors in the modern management of nonvariceal upper gastrointestinal bleeding.
Barkun AN
Drugs Today (Barc); 2003 Mar; 39 Suppl A():3-10. PubMed ID: 12712215
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding.
Dorward S; Sreedharan A; Leontiadis GI; Howden CW; Moayyedi P; Forman D
Cochrane Database Syst Rev; 2006 Oct; (4):CD005415. PubMed ID: 17054257
[TBL] [Abstract][Full Text] [Related]
13. Review article: the role of antisecretory therapy in the management of non-variceal upper gastrointestinal bleeding.
Triadafilopoulos G
Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():53-8. PubMed ID: 16303038
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
Gralnek IM; Dumonceau JM; Kuipers EJ; Lanas A; Sanders DS; Kurien M; Rotondano G; Hucl T; Dinis-Ribeiro M; Marmo R; Racz I; Arezzo A; Hoffmann RT; Lesur G; de Franchis R; Aabakken L; Veitch A; Radaelli F; Salgueiro P; Cardoso R; Maia L; Zullo A; Cipolletta L; Hassan C
Endoscopy; 2015 Oct; 47(10):a1-46. PubMed ID: 26417980
[TBL] [Abstract][Full Text] [Related]
15. Effect of intravenous proton pump inhibitor regimens and timing of endoscopy on clinical outcomes of peptic ulcer bleeding.
Liu N; Liu L; Zhang H; Gyawali PC; Zhang D; Yao L; Yang Y; Wu K; Ding J; Fan D
J Gastroenterol Hepatol; 2012 Sep; 27(9):1473-9. PubMed ID: 22646140
[TBL] [Abstract][Full Text] [Related]
16. [New data on the efficacy of proton pump inhibitors in upper gastrointestinal bleeding].
Calvet X
Gastroenterol Hepatol; 2010 May; 33 Suppl 1():11-4. PubMed ID: 20728784
[TBL] [Abstract][Full Text] [Related]
17. The cost-effectiveness and budget impact of intravenous versus oral proton pump inhibitors in peptic ulcer hemorrhage.
Spiegel BM; Dulai GS; Lim BS; Mann N; Kanwal F; Gralnek IM
Clin Gastroenterol Hepatol; 2006 Aug; 4(8):988-997. PubMed ID: 16844422
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitors therapy vs H2 receptor antagonists therapy for upper gastrointestinal bleeding after endoscopy: A meta-analysis.
Zhang YS; Li Q; He BS; Liu R; Li ZJ
World J Gastroenterol; 2015 May; 21(20):6341-51. PubMed ID: 26034370
[TBL] [Abstract][Full Text] [Related]
19. An observational European study on clinical outcomes associated with current management strategies for non-variceal upper gastrointestinal bleeding (ENERGIB-Turkey).
Mungan Z
Turk J Gastroenterol; 2012; 23(5):463-77. PubMed ID: 23161291
[TBL] [Abstract][Full Text] [Related]
20. Estimates of costs of hospital stay for variceal and nonvariceal upper gastrointestinal bleeding in the United States.
Adam V; Barkun AN
Value Health; 2008; 11(1):1-3. PubMed ID: 18237354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
